The Innovative Training Networks (ITN) aim to train a new generation of creative, entrepreneurial and innovative early-stage researchers, able to face current and future challenges and to convert knowledge and ideas into products and services for economic and social benefit. … Read more à proposHorizon 2020 : Marie Skłodowska-Curie ITN
FRM 2020 « Environnement et Santé »
L’exposition de l’Homme à des agents environnementaux (agents physiques ou chimiques, infectieux, contaminants alimentaires ainsi que divers stress et mode de vie, ...) peut avoir un impact sur sa santé. Ces agents,selon la durée mais aussi la fenêtre d’exposition en particulier pendant la période … Read more à proposFRM 2020 « Environnement et Santé »
CANCER CAMPUS : Appel à candidature « Dossier Onconumérique »
Cancer Campus lance un appel à candidature dans le secteur du numérique en lien avec l’oncologie. … Read more à proposCANCER CAMPUS : Appel à candidature « Dossier Onconumérique »
CANCER CAMPUS : Appel à candidature « Dossier Oncoentrepreneur »
Cancer Campus lance un appel à candidature dans le secteur de la santé en lien avec l'oncologie. … Read more à proposCANCER CAMPUS : Appel à candidature « Dossier Oncoentrepreneur »
ARS Paca : Prix régional de l’innovation en santé
Vous avez un projet dans le domaine de la santé ? La Région Sud et l’Agence régionale de la santé ont créé un Prix régional de l’innovation pour récompenser les projets les plus innovants à destination des patients, usagers et professionnels de la santé. … Read more à proposARS Paca : Prix régional de l’innovation en santé
ERC Proof of Concept Grant
Frontier research often generates unexpected or new opportunities for commercial or societal applications. The ERC Proof of Concept Grants aim to maximise the value of the excellent research that the ERC funds, by funding further work (i.e. activities which were not scheduled to be funded by the … Read more à proposERC Proof of Concept Grant
ERC Synergy Grant
The aim is to provide support for a small group of two to four Principal Investigators to jointly addressambitious research problems that could not be addressed by the individual Principal Investigators and their teams working alone. Synergy projects should enable substantial advances at the … Read more à proposERC Synergy Grant
ERC Starting Grant
ERC Starting Grants are designed to support excellent Principal Investigators at the career stage at which they are starting their own independent research team or programme. Principal Investigators must demonstrate the ground-breaking nature, ambition and feasibility of their scientific … Read more à proposERC Starting Grant
The Pablove Foundation: 2020 Seed Grant Opportunity
The Pablove Foundation improves the lives of children living with cancer through the arts and invests in underfunded, cutting edge pediatric cancer research. … Read more à proposThe Pablove Foundation: 2020 Seed Grant Opportunity
World Cancer Research Fund: Grant opportunity
World Cancer Research Fund (WCRF) is now accepting grant applications for research on the links between diet, nutrition (including body composition), physical activity and cancer, as part of its Regular Grant Programme 2019/2020 cycle. … Read more à proposWorld Cancer Research Fund: Grant opportunity
AstraZeneca Challenge: Molecular Strategies to Minimize Off-Target Toxicities of Antibody Drug Conjugates
An antibody-drug conjugate (ADC) is comprised of an antibody connected to a cytotoxic agent with a linker. ADCs are designed to selectively target tumors via binding to specific markers found on the cell surface. Although many ADCs are in clinical development, only a few are FDA approved. To … Read more à proposAstraZeneca Challenge: Molecular Strategies to Minimize Off-Target Toxicities of Antibody Drug Conjugates
AstraZeneca Challenge: Improving the Targeting and Transduction Efficiency of Adeno-Associated Viral Vectors
Adeno-associated virus (AAV) is a non-enveloped virus that infects humans with no known pathogenicity. With the ability to infect both dividing and non-dividing cells, AAVs are being studied as promising vehicles for targeted gene therapy. Therefore, AstraZeneca desires innovative approaches to … Read more à proposAstraZeneca Challenge: Improving the Targeting and Transduction Efficiency of Adeno-Associated Viral Vectors